BrightAccountsProduction v1.0.0 v1.0.0 2024-04-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts Specialist medical services 10 September 2025 1 1 08619291 2025-03-31 08619291 2024-03-31 08619291 2023-03-31 08619291 2024-04-01 2025-03-31 08619291 2023-04-01 2024-03-31 08619291 uk-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 08619291 uk-curr:PoundSterling 2024-04-01 2025-03-31 08619291 uk-bus:FullAccounts 2024-04-01 2025-03-31 08619291 uk-bus:Director1 2024-04-01 2025-03-31 08619291 uk-bus:Director2 2024-04-01 2025-03-31 08619291 uk-bus:RegisteredOffice 2024-04-01 2025-03-31 08619291 uk-bus:Agent1 2024-04-01 2025-03-31 08619291 uk-core:ShareCapital 2025-03-31 08619291 uk-core:ShareCapital 2024-03-31 08619291 uk-core:RetainedEarningsAccumulatedLosses 2025-03-31 08619291 uk-core:RetainedEarningsAccumulatedLosses 2024-03-31 08619291 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2025-03-31 08619291 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2024-03-31 08619291 uk-bus:FRS102 2024-04-01 2025-03-31 08619291 uk-core:CurrentFinancialInstruments 2025-03-31 08619291 uk-core:CurrentFinancialInstruments 2024-03-31 08619291 uk-core:WithinOneYear 2025-03-31 08619291 uk-core:WithinOneYear 2024-03-31 08619291 uk-core:AfterOneYear 2025-03-31 08619291 uk-core:AfterOneYear 2024-03-31 08619291 2024-04-01 2025-03-31 08619291 uk-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 xbrli:pure iso4217:GBP xbrli:shares

North Yorkshire Shoulder Surgeons Ltd.

Directors' Report and Unaudited Financial Statements

for the financial year ended 31 March 2025

North Yorkshire Shoulder Surgeons Ltd.

DIRECTORS AND OTHER INFORMATION

Directors | Raymond Liow
| Teresa Liow
Company Registration Number | 08619291
Registered Office | Cuckoo Wharf
| 427 Lichfield Road
| Birmingham
| B6 7SS
| United Kingdom
Business Address | 7 The Plantations
| Wynyard Wood
| Wynward
| TS22 5SN
Accountants | Capitax & Co (Tax Consultants) Ltd
| Cuckoo Wharf
| 427 Lichfield Road
| Birmingham
| West Midlands
| B6 7SS
| GB

North Yorkshire Shoulder Surgeons Ltd.

DIRECTORS' REPORT

for the financial year ended 31 March 2025

The directors present their report and the unaudited financial statements for the financial year ended 31 March 2025.

Principal Activity

Specialist medical services

Directors

The directors who served during the financial year are as follows:

Raymond Liow

Teresa Liow

There were no changes in shareholdings between 31 March 2025 and the date of signing the financial statements.

In accordance with the Constitution, the directors retire by rotation and, being eligible, offer themselves for re-election.

Political Contributions

The company did not make any disclosable political donations in the current financial year.

Statement of Directors' Responsibilities

The directors are responsible for preparing the Directors' Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland". Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

▪ | select suitable accounting policies and apply them consistently;
▪ | make judgements and accounting estimates that are reasonable and prudent;
▪ | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Special provisions relating to small companies

The above report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.

On behalf of the board

___________________________

Raymond Liow

Director

15 September 2025

North Yorkshire Shoulder Surgeons Ltd.

PROFIT AND LOSS ACCOUNT

for the financial year ended 31 March 2025

|  | 2025 |  | 2024
| Notes | £ |  | £

Turnover |  | 155,024 |  | 138,891
|  | ───────── |  | ─────────
Gross profit |  | 155,024 |  | 138,891
Administrative expenses |  | (106,351) |  | (99,827)
|  | ───────── |  | ─────────
Profit before taxation |  | 48,673 |  | 39,064
Tax on profit | 4 | (5,501) |  | -
|  | ───────── |  | ─────────
Profit for the financial year |  | 43,172 |  | 39,064
|  | ───────── |  | ─────────
Total comprehensive income |  | 43,172 |  | 39,064
|  | ═════════ |  | ═════════

North Yorkshire Shoulder Surgeons Ltd.

Company Registration Number: 08619291

BALANCE SHEET

as at 31 March 2025

|  |  | 2025 |  | 2024
|  | Notes | £ |  | £
Current Assets

Debtors |  | 5 | 22,506 |  | 16,005
Cash and cash equivalents |  |  | 465,473 |  | 424,456
|  |  | ───────── |  | ─────────
|  |  | 487,979 |  | 440,461
|  |  | ───────── |  | ─────────
Creditors: amounts falling due within one year |  | 6 | (9,818) |  | (3,935)
|  |  | ───────── |  | ─────────
Net Current Assets |  |  | 478,161 |  | 436,526
|  |  | ───────── |  | ─────────
Total Assets less Current Liabilities |  |  | 478,161 |  | 436,526
Creditors:

amounts falling due after more than one year |  | 7 | - |  | (37)
|  |  | ───────── |  | ─────────
Net Assets |  |  | 478,161 |  | 436,489
|  |  | ═════════ |  | ═════════
Capital and Reserves

Called up share capital |  |  | 140 |  | 140
Retained earnings |  |  | 478,021 |  | 436,349
|  |  | ───────── |  | ─────────
Equity attributable to owners of the company |  |  | 478,161 |  | 436,489
|  |  | ═════════ |  | ═════════
These financial statements have been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.

The directors confirm that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Approved by the Board and authorised for issue on 15 September 2025 and signed on its behalf by

________________________________ |  |  |  |  |
Raymond Liow |  |  |  |  |
Director |  |  |  |  |

North Yorkshire Shoulder Surgeons Ltd.

NOTES TO THE FINANCIAL STATEMENTS

for the financial year ended 31 March 2025

1. | General Information
| North Yorkshire Shoulder Surgeons Ltd. is a company limited by shares incorporated and registered in the United Kingdom. The registered number of the company is 08619291. The registered office of the company is Cuckoo Wharf, 427 Lichfield Road, Birmingham, B6 7SS, United Kingdom. Specialist medical services The financial statements have been presented in Pound (£) which is also the functional currency of the company.

2. | Summary of Significant Accounting Policies
| The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
| Statement of compliance
| The financial statements of the company for the financial year ended 31 March 2025 have been prepared in accordance with the Financial Reporting Standard applicable in the United Kingdom and the Republic of Ireland (FRS 102) issued by the Financial Reporting Council and in accordance with the Companies Act 2006.
| Basis of preparation
| The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
| Cash flow statement
| The company has availed of the exemption in FRS 102 from the requirement to prepare a Statement of Cash Flows because it is classified as a small company.
| Turnover
| Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.
| Trade and other debtors
| Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
| Borrowing costs
| Borrowing costs relating to the acquisition of assets are capitalised at the appropriate rate by adding them to the cost of assets being acquired. Investment income earned on the temporary investment of specific borrowings pending their expenditure on the assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.
| Trade and other creditors
| Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
| Employee benefits
| The company operates a salary sacrifice pension scheme.
| Taxation and deferred taxation
| Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date. Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date.
| Foreign currencies
| Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Balance Sheet date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Profit and Loss Account.
| Ordinary share capital
| The ordinary share capital of the company is presented as equity.

3. | Employees
| The average monthly number of employees, including directors, during the financial year was 1, (2024 - 1).
|  | 2025 | 2024
|  | Number | Number
| Directors | 1 | 1
|  | ═════════ | ═════════

4. | Tax on profit
|  | 2025 | 2024
|  | £ | £
| (a) Analysis of charge in the financial year
| Current tax:
| Corporation tax at 19.00% (2024 - 19.00%) (Note 4 (b)) | 5,501 | -
|  | ═════════ | ═════════
| (b) Factors affecting tax charge for the financial year
| The tax assessed for the financial year differs from the standard rate of corporation tax in United Kingdom 19.00% (2024 - 19.00%). The differences are explained below:
|  | 2025 | 2024
|  | £ | £
| Profit taxable at 19.00% | 48,673 | 39,064
|  | ═════════ | ═════════
| Profit before tax
| multiplied by the standard rate of corporation tax
| in United Kingdom at 19.00% (2024 - 19.00%) | 9,248 | 7,422
| Effects of:
| Utilisation of tax losses | (3,747) | (7,422)
|  | ───────── | ─────────
| Total tax charge for the financial year (Note 4 (a)) | 5,501 | -
|  | ═════════ | ═════════

5. | Debtors | 2025 | 2024
|  | £ | £
| Trade debtors | 2,672 | 2,672
| Debtors | 19,729 | 13,333
| Directors' current accounts (Note 10) | 105 | -
|  | ───────── | ─────────
|  | 22,506 | 16,005
|  | ═════════ | ═════════

6. | Creditors | 2025 | 2024
| Amounts falling due within one year | £ | £
| Taxation (Note 8) | 8,414 | 2,535
| Accruals | 1,404 | 1,400
|  | ───────── | ─────────
|  | 9,818 | 3,935
|  | ═════════ | ═════════

7. | Creditors | 2025 | 2024
| Amounts falling due after more than one year | £ | £
| Directors' loan accounts | - | 37
|  | ═════════ | ═════════

8. | Taxation | 2025 | 2024
|  | £ | £
| Creditors:
| Corporation tax | 5,501 | -
| PAYE / NI | 2,913 | 2,535
|  | ───────── | ─────────
|  | 8,414 | 2,535
|  | ═════════ | ═════════

9. | Capital commitments
| The company had no material capital commitments at the financial year-ended 31 March 2025.

10. | Directors' advances, credits and guarantees
| During the financial year, the company made no loan(s) to Director(s).

11. | Post-Balance Sheet Events
| There have been no significant events affecting the company since the financial year-end.